Sodium-glucose co-transporter-2 inhibitors and the risk of urosepsis: A multi-site, prevalent new-user cohort study.

Anat FisherMichael Fralick Kristian B FilionSophie Dell'AnielloAntonios DourosÉric TremblayBaiju R ShahPaul E RonksleySilvia Alessi-SeveriniNianping HuShawn C BugdenPierre ErnstLisa M Lixnull null

Published in: Diabetes, obesity & metabolism (2020)

In this large, multi-site study, we did not observe an increased risk for urosepsis associated with SGLT2i compared with DPP4i among patients with type 2 diabetes in a real-world setting.

Keyphrases